GeoVax Labs, Inc. (NASDAQ: GOVX) shares have observed a notable rise following the award of a substantial trial contract. During the pre-market session, GOVX shares
GeoVax Labs Inc. (NASDAQ: GOVX) is a biotechnology company that specializes in developing and commercializing treatments for various cancers and viral conditions. Many describe GeoVax
Yesterday, the vaccines developer biotech, GeoVax Labs Inc. (GOVX) announced a patent for its malaria vaccine candidate. Coming on the heels of a cancer vaccine
On 10th March 2021, GeoVax Labs Inc. (GOVX) got invited to present at the Maxim Group’s Inaugural Emerging Growth Virtual Conference that is to be held on
Shares of GeoVax Labs, Inc. (NASDAQ: GOVX) kicked off Monday’s session with an increase of 23.36% in its share prices. The strong performance of the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.